The French Microbiome company completed its first clinical study proving that Autologous Fecal Microbiota Transfer…
MaaT PharmaNovember 30, 2017
Maat Pharma has reached the target number of patients to be treated in its first…
MaaT PharmaJuly 20, 2017
Quality, safety and reproducibility: more than a medical device, a technological breakthrough in the field…
MaaT PharmaJune 15, 2017
Les Transferts de Microbiote Fécal (TMF) sont aujourd’hui utilisés afin de traiter certaines pathologies de…
MaaT PharmaMay 16, 2017
Les Transferts de Microbiote Fécal (TMF) sont aujourd’hui utilisés afin de traiter certaines pathologies de…
MaaT PharmaApril 20, 2017
MaaT Pharma and BIOASTER just entered into an agreement to investigate the potentiality to expand…
MaaT PharmaFebruary 16, 2017
Louis Schweitzer a pu découvrir la première plateforme européenne répondant aux normes BPF de transfert…
MaaT PharmaFebruary 3, 2017